Does BOTULINUM TOXIN TYPE A Cause Onychomadesis? 379 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 379 reports of Onychomadesis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 10.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
379
Reports of Onychomadesis with BOTULINUM TOXIN TYPE A
10.1%
of all BOTULINUM TOXIN TYPE A reports
378
Deaths
317
Hospitalizations
How Dangerous Is Onychomadesis From BOTULINUM TOXIN TYPE A?
Of the 379 reports, 378 (99.7%) resulted in death, 317 (83.6%) required hospitalization, and 319 (84.2%) were considered life-threatening.
Is Onychomadesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 379 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Onychomadesis?
ADALIMUMAB (797)
METHOTREXATE (785)
RITUXIMAB (722)
TOCILIZUMAB (721)
ABATACEPT (703)
INFLIXIMAB (682)
SECUKINUMAB (678)
LEFLUNOMIDE (667)
GOLIMUMAB (660)
HYDROXYCHLOROQUINE (660)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Onychomadesis Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE